Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rifaximin”

163 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 163 results

Early research (Phase 1)Study completedNCT01695174
What this trial is testing

A Pilot Study of Xifaxan to Treat Patients With PSC

Who this might be right for
Primary Sclerosing Cholangitis (PSC)
Mayo Clinic 16
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06783153
What this trial is testing

Efficacy and Safety of Adjunctive Use of Rifaximin In Preventing Radiotherapy-induced Diarrhea in Cancer Patients

Who this might be right for
Radiotherapy Induced DiarrheaAcute Radiation EnteritisProstate Cancer+5 more
Mansoura University 80
Testing effectiveness (Phase 2)UnknownNCT03719729
What this trial is testing

Rifaximin to Modify the Disease Course in Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseAntibiotics
New York Medical College 20
Large-scale testing (Phase 3)Study completedNCT00742469
What this trial is testing

Rifaximin for Prevention of Travellers' Diarrhea

Who this might be right for
Diarrhea
Bausch Health Americas, Inc. 210
Not applicableStudy completedNCT02498301
What this trial is testing

Trial Evaluating Chemoprophylaxis Against Travelers' Diarrhea - Prevent TD

Who this might be right for
Travelers' DiarrheaFunctional Bowel DisordersReactive Arthritis
Henry M. Jackson Foundation for the Advancement of Military Medicine 449
Large-scale testing (Phase 3)Study completedNCT01345175
What this trial is testing

Rifaximin and Placebo in the Treatment of Bowel Dysfunction After Anterior Resection for Rectal Cancer

Who this might be right for
Rectal Cancer
Memorial Sloan Kettering Cancer Center 69
Not applicableUnknownNCT03631147
What this trial is testing

The Effect of Rifaximin on Portal Vein Thrombosis

Who this might be right for
CirrhosisPortal Vein Thrombosis
Shanghai Zhongshan Hospital 96
Post-approval studies (Phase 4)Study completedNCT07037394
What this trial is testing

A Trial for Comparing Rifaximin, Probiotic and L-ornithine- L Aspartate With Lactulose in Overt Hepatic Encephalopathy.

Who this might be right for
Overt Hepatic Encephalopathy
Qurratul Ain Jamil 252
Post-approval studies (Phase 4)Study completedNCT04736836
What this trial is testing

Microbial Resistance of Rifaximin in Hepatic Encephalopathy

Who this might be right for
Hepatic Encephalopathy
National Hepatology & Tropical Medicine Research Institute 100
Testing effectiveness (Phase 2)Study completedNCT03856359
What this trial is testing

Trial of Rifaximin in Probable Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Duke University 10
Large-scale testing (Phase 3)UnknownNCT03962283
What this trial is testing

Rifaximin and Misoprostol Combination Therapy for Healing of Small Bowel Ulcers in Aspirin Users

Who this might be right for
Small Bowel DiseaseRifaximin
Chinese University of Hong Kong 78
Large-scale testing (Phase 3)UnknownNCT02508623
What this trial is testing

Effect of Administration of Rifaximin on the Portal Pressure of Patients With Liver Cirrhosis and Esophageal Varices

Who this might be right for
Liver CirrhosisPortal Hypertension
University of Padova 60
Testing effectiveness (Phase 2)Study completedNCT05098028
What this trial is testing

Pharmacokinetics and Pharmacodynamics of Rifaximin Novel Formulations in Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Bausch Health Americas, Inc. 44
Large-scale testing (Phase 3)WithdrawnNCT04244877
What this trial is testing

Rifaximin's Effect on Covert Hepatic Encephalopathy With SIBO and Gastrointestinal Dysmotility

Who this might be right for
Cirrhosis, LiverMinimal Hepatic EncephalopathySmall Intestinal Bacterial Overgrowth+1 more
MetroHealth Medical Center
Large-scale testing (Phase 3)UnknownNCT02485106
What this trial is testing

Rifaximin Use in Severe Alcoholic Hepatitis

Who this might be right for
Severe Alcoholic Hepatitis
Saint Vincent's Hospital, Korea 170
Post-approval studies (Phase 4)Looking for participantsNCT04073290
What this trial is testing

Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose

Who this might be right for
Hepatic EncephalopathyCirrhosis, LiverPortal Hypertension+2 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 238
Large-scale testing (Phase 3)Active Not RecruitingNCT05297448
What this trial is testing

Evaluation of Rifaximin SSD for Delaying Encephalopathy Decompensation in Patients With Cirrhosis

Who this might be right for
Hepatic Encephalopathy
Bausch Health Americas, Inc. 466
Testing effectiveness (Phase 2)UnknownNCT00281502
What this trial is testing

The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy

Who this might be right for
Hepatic EncephalopathyHepatitis CLiver Cirrhosis
Weill Medical College of Cornell University 50
Large-scale testing (Phase 3)Study completedNCT03695705
What this trial is testing

Rifaximin and Norfloxacin for Prevention of SBP in Adults With Decompensated Cirrhosis

Who this might be right for
Cirrhosis, Liver
Post Graduate Institute of Medical Education and Research, Chandigarh 142
Large-scale testing (Phase 3)Study completedNCT03780673
What this trial is testing

Efficacy of the Combination of Simvastatin Plus Rifaximin in Patients With Decompensated Cirrhosis to Prevent ACLF Development

Who this might be right for
Liver Cirrhoses
Judit Pich 254
Load More Results